Ohio Campaign To Block Marijuana And Hemp Restrictions Fails To Collect Enough Signatures For Ballot Referendum
“Marijuana will be re-criminalized in Ohio, businesses will close, workers will lose their jobs, and consumers will be denied their right to products they should be able to purchase.” By Megan Henry, Ohio Capital Journal Opponents of Ohio Republican lawmakers’ attempt to ban intoxicating hemp products and change the state’s voter-passed recreational marijuana law failed […]
New congressional cannabis rescheduling report (Newsletter: March 18, 2026)
Tom Angell is the editor of Marijuana Moment. A 25-year veteran in the cannabis and drug law reform movement, he covers the policy and politics of marijuana, psychedelics and other substances. He previously reported for Forbes, Marijuana.com and MassRoots, and was given the Hunter S. Thompson Media Award by NORML and has been named […]
Rhode Island Officials Support Ban On Serving Hemp THC Drinks In Bars And Restaurants With Liquor Licenses
“All retailers selling intoxicating hemp products should be held to similar high safety standards as cannabis retailers.” By Christopher Shea, Rhode Island Currant For a year, Rhode Island bars and restaurants had the opportunity to secure a license from the state’s former Office of Cannabis Regulation to sell intoxicating THC-infused beverages despite state regulations that […]
Congressional Researchers Give Update On Marijuana Rescheduling And Upcoming Hemp THC Ban
Congressional researchers are giving an update on the status of the federal-state marijuana law conflict, detailing the limitations of a pending rescheduling action, laying out options for lawmakers to address the issue and noting changes to hemp policy that are set to take effect later this year. Notably, the new report removes language from an […]
FDA Submits New Cannabis Products Enforcement Policy For White House Review
The Food and Drug Administration (FDA) has submitted a proposed cannabis products enforcement policy to the White House for review that concerns regulatory issues specifically related to CBD. The White House Office of Management and Budget’s (OMB) Office of Information and Regulatory Affairs (OIRA) posted a notice that it received the submission from FDA, which […]